Stocks
Dicerna Pharmaceuticals (DRNA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -0.24 | -1.24 | -3.34 | -9.92 | -10.2 | -20.7 | ||
| Changes by years, y/y, % | -90% | +427% | +169% | +197% | +3% | +34.0% | |||
Dicerna Pharmaceuticals. EV/EBITDA
Dicerna Pharmaceuticals. EV/EBITDA, changes, %
Dicerna Pharmaceuticals (DRNA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| EV/EBITDA | ? | -6.28 | -9.79 | -12.2 | -18.8 | -9.00 | -20.7 | |
| Changes by years, y/y, % | -2% | +5% | +130% | +99% | +43% | |||
| Changes by quarters, q/q, % | -33% | +56% | +25% | +54% | -52% | |||
